Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03480854 · ClinicalTrials.gov registry record · NA
The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 694
- Enrollment target
NCT03480854 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 694 participants.
The verdict
NCT03480854, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 694 participants
- Enrollment target
Study Summary
To establish the first systems level continuous quality improvement (CQI) collaborative for multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and assessments of geographic variation in MS care quality and value, and study the effect of CQI interventions on improvement of selected performance (quality) indicators.
Interventions
- OTHER Quality Improvement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 694 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03480854
The ClinicalTrials.gov registry entry for NCT03480854 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 694 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quality Improvement is the first listed.
NCT03480854 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03480854 about?
NCT03480854 is a clinical study titled "The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative". To establish the first systems level continuous quality improvement (CQI) collaborative for multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and assessments of geographic variation in MS care quality and value, and study the effect of CQI interventions on improvement of...
What is the current status of trial NCT03480854?
This trial is currently completed. It is a NA study. The enrollment target is 694 participants. The study started on 2017-07-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03480854?
The interventions under investigation include: Quality Improvement (OTHER).
Who is sponsoring clinical trial NCT03480854?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.